Brief: Alzinova Provides Future Sales Forecast For ALZ-101
23/06/2025 08:17
June 23 (Reuters) - Alzinova AB ALZ.ST: PROJECTS PEAK SALES POTENTIAL FOR ALZ-101 OF OVER $5.4 BLN AND TOTAL SALES EXCEEDING $62.5 BLN OVER DRUG'S ESTIMATED LIFESPAN ESTIMATES MARKET VALUE FOR ALZ-101 FROM $130–200 MLN WITH PARTNERSHIP ESTABLISHED BEFORE PHASE 2, AND FROM $780–1,100 MLN WITH PARTNERSHIP AFTER PHASE 2 ESTIMATES PROBABILITY OF MARKET APPROVAL AT 15% PRIOR TO INITIATING PHASE 2, AND 50% FOLLOWING ITS COMPLETION Source text for Workspace: ID:nMFN70CnTJ Further company coverage: ALZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))